Myovant Sciences Ltd.
MYOV
Transaktioner
484
Köp
274
Sälj
210
Nettoinsynsflöde
5.7 mdr USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
Ingen prisdata ännuIngen prisserie har matchats mot detta bolag ännu.
Avkastning efter transaktion
Median-% efter transaktionsdatumKursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
484 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2023-03-10 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 87 k | – | – |
| 2023-03-10 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 160 k | – | – |
| 2023-03-10 | Curran Terrie | Director | Sell | 4 k | – | – |
| 2023-03-10 | GUINAN MARK | Director | Sell | 4 k | – | – |
| 2023-03-10 | Gulfo Adele M. | Director | Sell | 4 k | – | – |
| 2023-03-10 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 113 k | – | – |
| 2023-03-10 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 241 k | – | – |
| 2023-03-10 | Marek David C | Principal Executive Officer | Sell | 96 k | – | – |
| 2023-03-10 | Marek David C | Principal Executive Officer | Sell | 322 k | – | – |
| 2023-03-10 | Mehra Uneek | Principal Financial Officer | Sell | 21 k | – | – |
| 2023-03-10 | Mehra Uneek | Principal Financial Officer | Sell | 182 k | – | – |
| 2023-03-10 | Merendino Lauren | Chief Commercial Officer | Sell | 22 k | – | – |
| 2023-03-10 | Merendino Lauren | Chief Commercial Officer | Sell | 148 k | – | – |
| 2023-03-10 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 51.6 mn | 27,00 | 1.4 mdr USD |
| 2023-03-10 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 87 k | – | – |
| 2023-03-10 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 160 k | – | – |
| 2023-03-10 | Curran Terrie | Director | Sell | 4 k | – | – |
| 2023-03-10 | GUINAN MARK | Director | Sell | 4 k | – | – |
| 2023-03-10 | Gulfo Adele M. | Director | Sell | 4 k | – | – |
| 2023-03-10 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 113 k | – | – |
| 2023-03-10 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 241 k | – | – |
| 2023-03-10 | Marek David C | Principal Executive Officer | Sell | 96 k | – | – |
| 2023-03-10 | Marek David C | Principal Executive Officer | Sell | 322 k | – | – |
| 2023-03-10 | Mehra Uneek | Principal Financial Officer | Sell | 21 k | – | – |
| 2023-03-10 | Mehra Uneek | Principal Financial Officer | Sell | 182 k | – | – |
| 2023-03-10 | Merendino Lauren | Chief Commercial Officer | Sell | 22 k | – | – |
| 2023-03-10 | Merendino Lauren | Chief Commercial Officer | Sell | 148 k | – | – |
| 2023-03-10 | POTTER MYRTLE S | Director | Sell | 4 k | – | – |
| 2023-03-10 | Valente Nancy | Director | Sell | 4 k | – | – |
| 2023-03-10 | POTTER MYRTLE S | Director | Sell | 4 k | – | – |
| 2023-03-10 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 51.6 mn | 27,00 | 1.4 mdr USD |
| 2023-03-10 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 51.6 mn | 27,00 | 1.4 mdr USD |
| 2023-03-10 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 51.6 mn | 27,00 | 1.4 mdr USD |
| 2023-03-10 | Valente Nancy | Director | Sell | 4 k | – | – |
| 2023-03-03 | Sumitomo Chemical Co., Ltd. | 10% owner | Sell | 4.2 mn | 0,00 | 0 USD |
| 2023-03-03 | Sumitomo Chemical Co., Ltd. | 10% owner | Sell | 4.2 mn | 0,00 | 0 USD |
| 2023-03-03 | Sumitomo Chemical Co., Ltd. | 10% owner | Sell | 4.2 mn | 0,00 | 0 USD |
| 2023-03-03 | Sumitomo Chemical Co., Ltd. | 10% owner | Sell | 4.2 mn | 0,00 | 0 USD |
| 2023-01-18 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 1 k | 26,89 | 30 k USD |
| 2023-01-18 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 1 k | 26,89 | 34 k USD |
| 2023-01-18 | Marek David C | Principal Executive Officer | Sell | 8 k | 26,89 | 216 k USD |
| 2023-01-18 | Merendino Lauren | Chief Commercial Officer | Sell | 2 k | 26,89 | 54 k USD |
| 2023-01-18 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 1 k | 26,89 | 30 k USD |
| 2023-01-18 | Marek David C | Principal Executive Officer | Sell | 8 k | 26,89 | 216 k USD |
| 2023-01-18 | Merendino Lauren | Chief Commercial Officer | Sell | 2 k | 26,89 | 54 k USD |
| 2023-01-18 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 1 k | 26,89 | 34 k USD |
| 2023-01-04 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 26,90 | 61 k USD |
| 2023-01-04 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 3 k | 26,90 | 75 k USD |
| 2023-01-04 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 3 k | 26,90 | 75 k USD |
| 2023-01-04 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 26,90 | 61 k USD |
| 2022-12-16 | Mehra Uneek | Principal Financial Officer | Sell | 2 k | 26,75 | 60 k USD |
| 2022-12-16 | Mehra Uneek | Principal Financial Officer | Sell | 2 k | 26,75 | 60 k USD |
| 2022-10-26 | Curran Terrie | Director | Buy | 10 k | 0,00 | 0 USD |
| 2022-10-26 | GUINAN MARK | Director | Buy | 10 k | 0,00 | 0 USD |
| 2022-10-26 | Gulfo Adele M. | Director | Buy | 10 k | 0,00 | 0 USD |
| 2022-10-26 | Valente Nancy | Director | Buy | 10 k | 0,00 | 0 USD |
| 2022-10-26 | POTTER MYRTLE S | Director | Buy | 10 k | 0,00 | 0 USD |
| 2022-10-26 | Gulfo Adele M. | Director | Buy | 10 k | 0,00 | 0 USD |
| 2022-10-26 | GUINAN MARK | Director | Buy | 10 k | 0,00 | 0 USD |
| 2022-10-26 | Curran Terrie | Director | Buy | 10 k | 0,00 | 0 USD |
| 2022-10-26 | POTTER MYRTLE S | Director | Buy | 10 k | 0,00 | 0 USD |
| 2022-10-26 | Valente Nancy | Director | Buy | 10 k | 0,00 | 0 USD |
| 2022-10-18 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 25,20 | 40 k USD |
| 2022-10-18 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 2 k | 25,20 | 49 k USD |
| 2022-10-18 | Marek David C | Principal Executive Officer | Sell | 11 k | 25,20 | 281 k USD |
| 2022-10-18 | Merendino Lauren | Chief Commercial Officer | Sell | 2 k | 25,20 | 43 k USD |
| 2022-10-18 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 25,20 | 40 k USD |
| 2022-10-18 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 2 k | 25,20 | 49 k USD |
| 2022-10-18 | Marek David C | Principal Executive Officer | Sell | 11 k | 25,20 | 281 k USD |
| 2022-10-18 | Merendino Lauren | Chief Commercial Officer | Sell | 2 k | 25,20 | 43 k USD |
| 2022-10-04 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 3 k | 24,40 | 67 k USD |
| 2022-10-04 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 4 k | 24,40 | 90 k USD |
| 2022-10-04 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 4 k | 24,40 | 90 k USD |
| 2022-10-04 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 3 k | 24,40 | 67 k USD |
| 2022-09-16 | Mehra Uneek | Principal Financial Officer | Sell | 9 k | 18,86 | 174 k USD |
| 2022-09-16 | Mehra Uneek | Principal Financial Officer | Sell | 9 k | 18,86 | 174 k USD |
| 2022-08-15 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 31 k | 18,23 | 569 k USD |
| 2022-08-15 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 31 k | 18,23 | 569 k USD |
| 2022-08-12 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 125 k | 0,00 | 0 USD |
| 2022-08-12 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 125 k | 0,00 | 0 USD |
| 2022-07-18 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 12,87 | 21 k USD |
| 2022-07-18 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 2 k | 12,87 | 25 k USD |
| 2022-07-18 | Marek David C | Principal Executive Officer | Sell | 11 k | 12,87 | 144 k USD |
| 2022-07-18 | Merendino Lauren | Chief Commercial Officer | Sell | 2 k | 12,87 | 22 k USD |
| 2022-07-18 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 12,87 | 21 k USD |
| 2022-07-18 | Marek David C | Principal Executive Officer | Sell | 11 k | 12,87 | 144 k USD |
| 2022-07-18 | Merendino Lauren | Chief Commercial Officer | Sell | 2 k | 12,87 | 22 k USD |
| 2022-07-18 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 2 k | 12,87 | 25 k USD |
| 2022-07-06 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 3 k | 13,40 | 37 k USD |
| 2022-07-06 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 4 k | 13,40 | 50 k USD |
| 2022-07-06 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 4 k | 13,40 | 50 k USD |
| 2022-07-06 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 3 k | 13,40 | 37 k USD |
| 2022-05-27 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 1 k | 10,07 | 14 k USD |
| 2022-05-27 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 1 k | 10,07 | 14 k USD |
| 2022-04-19 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 5 k | 10,45 | 48 k USD |
| 2022-04-19 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 8 k | 10,45 | 84 k USD |
| 2022-04-19 | Marek David C | Principal Executive Officer | Sell | 25 k | 10,45 | 257 k USD |
| 2022-04-19 | Merendino Lauren | Chief Commercial Officer | Sell | 7 k | 10,45 | 74 k USD |
| 2022-04-19 | Marek David C | Principal Executive Officer | Sell | 25 k | 10,45 | 257 k USD |
| 2022-04-19 | Merendino Lauren | Chief Commercial Officer | Sell | 7 k | 10,45 | 74 k USD |
| 2022-04-19 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 5 k | 10,45 | 48 k USD |
| 2022-04-19 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 8 k | 10,45 | 84 k USD |
| 2022-04-15 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 104 k | 0,00 | 0 USD |
| 2022-04-15 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 111 k | 0,00 | 0 USD |
| 2022-04-15 | Marek David C | Principal Executive Officer | Buy | 135 k | 0,00 | 0 USD |
| 2022-04-15 | Mehra Uneek | Principal Financial Officer | Buy | 111 k | 0,00 | 0 USD |
| 2022-04-15 | Merendino Lauren | Chief Commercial Officer | Buy | 104 k | 0,00 | 0 USD |
| 2022-04-15 | Marek David C | Principal Executive Officer | Buy | 135 k | 0,00 | 0 USD |
| 2022-04-15 | Merendino Lauren | Chief Commercial Officer | Buy | 104 k | 0,00 | 0 USD |
| 2022-04-15 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 111 k | 0,00 | 0 USD |
| 2022-04-15 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 104 k | 0,00 | 0 USD |
| 2022-04-15 | Mehra Uneek | Principal Financial Officer | Buy | 111 k | 0,00 | 0 USD |
| 2022-04-05 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 13,78 | 26 k USD |
| 2022-04-05 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 2 k | 13,78 | 34 k USD |
| 2022-04-05 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 13,78 | 26 k USD |
| 2022-04-05 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 2 k | 13,78 | 34 k USD |
| 2022-03-01 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 1 k | 13,35 | 18 k USD |
| 2022-03-01 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 1 k | 13,35 | 18 k USD |
| 2022-01-19 | Marek David C | Principal Executive Officer | Sell | 20 k | 14,68 | 292 k USD |
| 2022-01-19 | Marek David C | Principal Executive Officer | Sell | 20 k | 14,68 | 292 k USD |
| 2022-01-04 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 16,27 | 37 k USD |
| 2022-01-04 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 4 k | 16,27 | 73 k USD |
| 2022-01-04 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 16,27 | 37 k USD |
| 2022-01-04 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 4 k | 16,27 | 73 k USD |
| 2021-11-29 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 19,30 | 38 k USD |
| 2021-11-29 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 19,30 | 38 k USD |
| 2021-11-04 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 3 k | 7,78 | 24 k USD |
| 2021-11-04 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 3 k | 24,02 | 74 k USD |
| 2021-11-03 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 700 | 7,78 | 5 k USD |
| 2021-11-03 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 700 | 24,00 | 17 k USD |
| 2021-10-05 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 3 k | 21,62 | 59 k USD |
| 2021-10-05 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 7 k | 21,62 | 144 k USD |
| 2021-10-05 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 7 k | 21,62 | 144 k USD |
| 2021-10-05 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 3 k | 21,62 | 59 k USD |
| 2021-09-28 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 21 k | 22,85 | 472 k USD |
| 2021-09-28 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 21 k | 22,85 | 472 k USD |
| 2021-09-28 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 21 k | 22,85 | 472 k USD |
| 2021-09-28 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 21 k | 22,85 | 472 k USD |
| 2021-09-27 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 7 k | 7,78 | 54 k USD |
| 2021-09-27 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 7 k | 24,32 | 170 k USD |
| 2021-09-27 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 7 k | 7,78 | 54 k USD |
| 2021-09-27 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 7 k | 24,32 | 170 k USD |
| 2021-09-27 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 46 k | 24,19 | 1.1 mn USD |
| 2021-09-27 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 2 k | 24,86 | 55 k USD |
| 2021-09-27 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 46 k | 24,19 | 1.1 mn USD |
| 2021-09-27 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 2 k | 24,86 | 55 k USD |
| 2021-09-27 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 46 k | 24,19 | 1.1 mn USD |
| 2021-09-27 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 2 k | 24,86 | 55 k USD |
| 2021-09-27 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 46 k | 24,19 | 1.1 mn USD |
| 2021-09-27 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 2 k | 24,86 | 55 k USD |
| 2021-09-24 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 36 k | 23,40 | 843 k USD |
| 2021-09-24 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 36 k | 23,40 | 843 k USD |
| 2021-09-24 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 36 k | 23,40 | 843 k USD |
| 2021-09-24 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 36 k | 23,40 | 843 k USD |
| 2021-09-23 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 49 k | 23,01 | 1.1 mn USD |
| 2021-09-23 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 5 k | 23,49 | 125 k USD |
| 2021-09-23 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 49 k | 23,01 | 1.1 mn USD |
| 2021-09-23 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 5 k | 23,49 | 125 k USD |
| 2021-09-23 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 49 k | 23,01 | 1.1 mn USD |
| 2021-09-23 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 5 k | 23,49 | 125 k USD |
| 2021-09-23 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 49 k | 23,01 | 1.1 mn USD |
| 2021-09-23 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 5 k | 23,49 | 125 k USD |
| 2021-09-22 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 84 k | 21,96 | 1.8 mn USD |
| 2021-09-22 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 84 k | 21,96 | 1.8 mn USD |
| 2021-09-22 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 84 k | 21,96 | 1.8 mn USD |
| 2021-09-22 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 84 k | 21,96 | 1.8 mn USD |
| 2021-09-21 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 43 k | 22,48 | 966 k USD |
| 2021-09-21 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 43 k | 22,48 | 966 k USD |
| 2021-09-21 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 43 k | 22,48 | 966 k USD |
| 2021-09-20 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 38 k | 22,10 | 846 k USD |
| 2021-09-20 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 38 k | 22,10 | 846 k USD |
| 2021-09-20 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 38 k | 22,10 | 846 k USD |
| 2021-09-17 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 38 k | 22,79 | 864 k USD |
| 2021-09-17 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 38 k | 22,79 | 864 k USD |
| 2021-09-17 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 38 k | 22,79 | 864 k USD |
| 2021-09-17 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 38 k | 22,79 | 864 k USD |
| 2021-09-16 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 50 k | 21,75 | 1.1 mn USD |
| 2021-09-16 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 50 k | 21,75 | 1.1 mn USD |
| 2021-09-16 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 50 k | 21,75 | 1.1 mn USD |
| 2021-09-16 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 50 k | 21,75 | 1.1 mn USD |
| 2021-09-15 | Mehra Uneek | Principal Financial Officer | Buy | 103 k | 0,00 | 0 USD |
| 2021-09-15 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 90 k | 21,98 | 2.0 mn USD |
| 2021-09-15 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 90 k | 21,98 | 2.0 mn USD |
| 2021-09-15 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 90 k | 21,98 | 2.0 mn USD |
| 2021-09-15 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 90 k | 21,98 | 2.0 mn USD |
| 2021-09-14 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 65 k | 22,04 | 1.4 mn USD |
| 2021-09-14 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 6 k | 22,76 | 140 k USD |
| 2021-09-14 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 65 k | 22,04 | 1.4 mn USD |
| 2021-09-14 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 6 k | 22,76 | 140 k USD |
| 2021-09-14 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 65 k | 22,04 | 1.4 mn USD |
| 2021-09-14 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 6 k | 22,76 | 140 k USD |
| 2021-09-14 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 65 k | 22,04 | 1.4 mn USD |
| 2021-09-14 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 6 k | 22,76 | 140 k USD |
| 2021-09-13 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 53 k | 23,09 | 1.2 mn USD |
| 2021-09-13 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 30 k | 23,91 | 718 k USD |
| 2021-09-13 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 53 k | 23,09 | 1.2 mn USD |
| 2021-09-13 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 30 k | 23,91 | 718 k USD |
| 2021-09-13 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 53 k | 23,09 | 1.2 mn USD |
| 2021-09-13 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 30 k | 23,91 | 718 k USD |
| 2021-09-10 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 30 k | 25,11 | 753 k USD |
| 2021-09-10 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 30 k | 25,11 | 753 k USD |
| 2021-09-10 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 30 k | 25,11 | 753 k USD |
| 2021-09-09 | Curran Terrie | Director | Buy | 5 k | 7,65 | 37 k USD |
| 2021-09-09 | Curran Terrie | Director | Sell | 5 k | 25,58 | 124 k USD |
| 2021-09-09 | Curran Terrie | Director | Buy | 5 k | 7,65 | 37 k USD |
| 2021-09-09 | Curran Terrie | Director | Sell | 5 k | 25,58 | 124 k USD |
| 2021-09-09 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 37 k | 25,52 | 944 k USD |
| 2021-09-09 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 37 k | 25,52 | 944 k USD |
| 2021-09-09 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 37 k | 25,52 | 944 k USD |
| 2021-09-09 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 37 k | 25,52 | 944 k USD |
| 2021-09-08 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 22 k | 25,74 | 564 k USD |
| 2021-09-08 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 22 k | 25,74 | 564 k USD |
| 2021-09-08 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 22 k | 25,74 | 564 k USD |
| 2021-09-08 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 22 k | 25,74 | 564 k USD |
| 2021-09-07 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 28 k | 26,08 | 738 k USD |
| 2021-09-07 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 5 k | 27,12 | 133 k USD |
| 2021-09-07 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 28 k | 26,08 | 738 k USD |
| 2021-09-07 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 5 k | 27,12 | 133 k USD |
| 2021-09-07 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 28 k | 26,08 | 738 k USD |
| 2021-09-07 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 5 k | 27,12 | 133 k USD |
| 2021-09-07 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 28 k | 26,08 | 738 k USD |
| 2021-09-07 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 5 k | 27,12 | 133 k USD |
| 2021-09-03 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 30 k | 26,74 | 797 k USD |
| 2021-09-03 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 1 k | 27,29 | 38 k USD |
| 2021-09-03 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 30 k | 26,74 | 797 k USD |
| 2021-09-03 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 1 k | 27,29 | 38 k USD |
| 2021-09-03 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 30 k | 26,74 | 797 k USD |
| 2021-09-03 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 1 k | 27,29 | 38 k USD |
| 2021-09-03 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 30 k | 26,74 | 797 k USD |
| 2021-09-03 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 1 k | 27,29 | 38 k USD |
| 2021-09-02 | Curran Terrie | Director | Buy | 37 k | 7,65 | 284 k USD |
| 2021-09-02 | Curran Terrie | Director | Sell | 37 k | 25,03 | 929 k USD |
| 2021-09-02 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 22 k | 25,25 | 561 k USD |
| 2021-09-02 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 35 k | 26,46 | 927 k USD |
| 2021-09-02 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 6 k | 26,95 | 158 k USD |
| 2021-09-02 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 22 k | 25,25 | 561 k USD |
| 2021-09-02 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 35 k | 26,46 | 927 k USD |
| 2021-09-02 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 6 k | 26,95 | 158 k USD |
| 2021-09-02 | Curran Terrie | Director | Buy | 37 k | 7,65 | 284 k USD |
| 2021-09-02 | Curran Terrie | Director | Sell | 37 k | 25,03 | 929 k USD |
| 2021-09-02 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 22 k | 25,25 | 561 k USD |
| 2021-09-02 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 35 k | 26,46 | 927 k USD |
| 2021-09-02 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 6 k | 26,95 | 158 k USD |
| 2021-09-02 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 22 k | 25,25 | 561 k USD |
| 2021-09-02 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 35 k | 26,46 | 927 k USD |
| 2021-09-02 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 6 k | 26,95 | 158 k USD |
| 2021-09-01 | Curran Terrie | Director | Buy | 11 k | 7,65 | 87 k USD |
| 2021-09-01 | Curran Terrie | Director | Sell | 11 k | 25,00 | 284 k USD |
| 2021-09-01 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 40 k | 24,83 | 993 k USD |
| 2021-09-01 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 40 k | 24,83 | 993 k USD |
| 2021-09-01 | Curran Terrie | Director | Buy | 11 k | 7,65 | 87 k USD |
| 2021-09-01 | Curran Terrie | Director | Sell | 11 k | 25,00 | 284 k USD |
| 2021-09-01 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 40 k | 24,83 | 993 k USD |
| 2021-09-01 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 40 k | 24,83 | 993 k USD |
| 2021-08-31 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 39 k | 24,28 | 947 k USD |
| 2021-08-31 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 39 k | 24,28 | 947 k USD |
| 2021-08-31 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 39 k | 24,28 | 947 k USD |
| 2021-08-31 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 39 k | 24,28 | 947 k USD |
| 2021-08-30 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 70 k | 23,92 | 1.7 mn USD |
| 2021-08-30 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 70 k | 23,92 | 1.7 mn USD |
| 2021-08-30 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 70 k | 23,92 | 1.7 mn USD |
| 2021-08-30 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 70 k | 23,92 | 1.7 mn USD |
| 2021-08-30 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 21 k | 7,78 | 163 k USD |
| 2021-08-30 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 21 k | 24,05 | 505 k USD |
| 2021-08-30 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 21 k | 7,78 | 163 k USD |
| 2021-08-30 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 21 k | 24,05 | 505 k USD |
| 2021-08-27 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 22,69 | 45 k USD |
| 2021-08-27 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 22,69 | 45 k USD |
| 2021-08-27 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 37 k | 23,17 | 858 k USD |
| 2021-08-27 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 37 k | 23,17 | 858 k USD |
| 2021-08-27 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 37 k | 23,17 | 858 k USD |
| 2021-08-27 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 37 k | 23,17 | 858 k USD |
| 2021-08-26 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 40 k | 22,67 | 907 k USD |
| 2021-08-26 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 40 k | 22,67 | 907 k USD |
| 2021-08-26 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 40 k | 22,67 | 907 k USD |
| 2021-08-26 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 40 k | 22,67 | 907 k USD |
| 2021-08-25 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 29 k | 22,44 | 644 k USD |
| 2021-08-25 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 29 k | 22,44 | 644 k USD |
| 2021-08-25 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 29 k | 22,44 | 644 k USD |
| 2021-08-25 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 29 k | 22,44 | 644 k USD |
| 2021-08-24 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 34 k | 22,37 | 767 k USD |
| 2021-08-24 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 34 k | 22,37 | 767 k USD |
| 2021-08-24 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 34 k | 22,37 | 767 k USD |
| 2021-08-24 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 34 k | 22,37 | 767 k USD |
| 2021-08-23 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 25 k | 22,13 | 554 k USD |
| 2021-08-23 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 30 k | 22,45 | 682 k USD |
| 2021-08-23 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 25 k | 22,13 | 554 k USD |
| 2021-08-23 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 30 k | 22,45 | 682 k USD |
| 2021-08-23 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 25 k | 22,13 | 554 k USD |
| 2021-08-23 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 30 k | 22,45 | 682 k USD |
| 2021-08-23 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 25 k | 22,13 | 554 k USD |
| 2021-08-23 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 30 k | 22,45 | 682 k USD |
| 2021-08-20 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 46 k | 20,86 | 970 k USD |
| 2021-08-20 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 46 k | 20,86 | 970 k USD |
| 2021-08-20 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 46 k | 20,86 | 970 k USD |
| 2021-08-20 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 46 k | 20,86 | 970 k USD |
| 2021-08-19 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 47 k | 21,51 | 1.0 mn USD |
| 2021-08-19 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 47 k | 21,51 | 1.0 mn USD |
| 2021-08-19 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 47 k | 21,51 | 1.0 mn USD |
| 2021-08-19 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 47 k | 21,51 | 1.0 mn USD |
| 2021-08-18 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 17 k | 21,45 | 367 k USD |
| 2021-08-18 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 17 k | 21,45 | 367 k USD |
| 2021-08-18 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 17 k | 21,45 | 367 k USD |
| 2021-08-18 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 17 k | 21,45 | 367 k USD |
| 2021-08-17 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 24 k | 20,89 | 492 k USD |
| 2021-08-17 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 24 k | 20,89 | 492 k USD |
| 2021-08-17 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 24 k | 20,89 | 492 k USD |
| 2021-08-17 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 24 k | 20,89 | 492 k USD |
| 2021-08-16 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 43 k | 21,29 | 911 k USD |
| 2021-08-16 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 5 k | 21,94 | 118 k USD |
| 2021-08-16 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 43 k | 21,29 | 911 k USD |
| 2021-08-16 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 5 k | 21,94 | 118 k USD |
| 2021-08-16 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 43 k | 21,29 | 911 k USD |
| 2021-08-16 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 5 k | 21,94 | 118 k USD |
| 2021-08-16 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 43 k | 21,29 | 911 k USD |
| 2021-08-16 | Sumitomo Chemical Co., Ltd. | 10% owner | Buy | 5 k | 21,94 | 118 k USD |
| 2021-07-09 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 7 k | 21,52 | 150 k USD |
| 2021-07-09 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 7 k | 21,52 | 150 k USD |
| 2021-07-07 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 3 k | 21,75 | 60 k USD |
| 2021-07-07 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 3 k | 21,75 | 70 k USD |
| 2021-07-07 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 3 k | 21,75 | 70 k USD |
| 2021-07-07 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 3 k | 21,75 | 60 k USD |
| 2021-05-28 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 1 k | 7,78 | 10 k USD |
| 2021-05-28 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 1 k | 24,00 | 31 k USD |
| 2021-05-28 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 24,00 | 43 k USD |
| 2021-05-28 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 1 k | 7,78 | 10 k USD |
| 2021-05-28 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 1 k | 24,00 | 31 k USD |
| 2021-05-28 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 24,00 | 43 k USD |
| 2021-05-26 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 13 k | 7,78 | 99 k USD |
| 2021-05-26 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 13 k | 24,23 | 308 k USD |
| 2021-05-26 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 13 k | 7,78 | 99 k USD |
| 2021-05-26 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 13 k | 24,23 | 308 k USD |
| 2021-04-15 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 51 k | 0,00 | 0 USD |
| 2021-04-15 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 63 k | 0,00 | 0 USD |
| 2021-04-15 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 58 k | 0,00 | 0 USD |
| 2021-04-15 | Marek David C | Principal Executive Officer | Buy | 135 k | 0,00 | 0 USD |
| 2021-04-15 | Merendino Lauren | Chief Commercial Officer | Buy | 78 k | 0,00 | 0 USD |
| 2021-04-15 | Merendino Lauren | Chief Commercial Officer | Buy | 78 k | 0,00 | 0 USD |
| 2021-04-15 | Marek David C | Principal Executive Officer | Buy | 135 k | 0,00 | 0 USD |
| 2021-04-15 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 63 k | 0,00 | 0 USD |
| 2021-04-15 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 51 k | 0,00 | 0 USD |
| 2021-04-15 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 58 k | 0,00 | 0 USD |
| 2021-04-06 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 8 k | 18,63 | 151 k USD |
| 2021-04-06 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 11 k | 18,63 | 206 k USD |
| 2021-04-06 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 11 k | 18,62 | 202 k USD |
| 2021-04-06 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 11 k | 18,63 | 206 k USD |
| 2021-04-06 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 11 k | 18,62 | 202 k USD |
| 2021-04-06 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 8 k | 18,63 | 151 k USD |
| 2021-03-19 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 7 k | 7,78 | 54 k USD |
| 2021-03-19 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 7 k | 24,17 | 169 k USD |
| 2021-03-19 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 7 k | 7,78 | 54 k USD |
| 2021-03-19 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 7 k | 24,17 | 169 k USD |
| 2021-03-15 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 30 k | 7,78 | 233 k USD |
| 2021-03-15 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 30 k | 25,07 | 752 k USD |
| 2021-03-15 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 30 k | 7,78 | 233 k USD |
| 2021-03-15 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 30 k | 25,07 | 752 k USD |
| 2021-03-01 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 22,55 | 34 k USD |
| 2021-03-01 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 22,55 | 34 k USD |
| 2021-02-16 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 750 | 5,11 | 4 k USD |
| 2021-02-16 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 750 | 21,40 | 16 k USD |
| 2021-02-16 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 750 | 5,11 | 4 k USD |
| 2021-02-16 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 750 | 21,40 | 16 k USD |
| 2021-01-28 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 300 | 5,11 | 2 k USD |
| 2021-01-28 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 300 | 24,00 | 7 k USD |
| 2021-01-28 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 300 | 5,11 | 2 k USD |
| 2021-01-28 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 300 | 24,00 | 7 k USD |
| 2021-01-15 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 750 | 5,11 | 4 k USD |
| 2021-01-15 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 750 | 21,50 | 16 k USD |
| 2021-01-15 | Marek David C | Principal Executive Officer | Buy | 223 k | 0,00 | 0 USD |
| 2021-01-15 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 750 | 5,11 | 4 k USD |
| 2021-01-15 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 750 | 21,50 | 16 k USD |
| 2021-01-15 | Marek David C | Principal Executive Officer | Buy | 223 k | 0,00 | 0 USD |
| 2020-12-28 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 12 k | 5,11 | 60 k USD |
| 2020-12-28 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 12 k | 30,00 | 354 k USD |
| 2020-12-28 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 12 k | 5,11 | 60 k USD |
| 2020-12-28 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 12 k | 30,00 | 354 k USD |
| 2020-12-18 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 2 k | 7,78 | 16 k USD |
| 2020-12-18 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 26,00 | 52 k USD |
| 2020-12-18 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 10 k | 7,78 | 78 k USD |
| 2020-12-18 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 10 k | 25,38 | 246 k USD |
| 2020-12-18 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 300 | 26,24 | 8 k USD |
| 2020-12-18 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 10 k | 7,78 | 78 k USD |
| 2020-12-18 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 10 k | 25,38 | 246 k USD |
| 2020-12-18 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 300 | 26,24 | 8 k USD |
| 2020-12-18 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 2 k | 7,78 | 16 k USD |
| 2020-12-18 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 26,00 | 52 k USD |
| 2020-12-15 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 7 k | 7,78 | 54 k USD |
| 2020-12-15 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 4 k | 23,66 | 84 k USD |
| 2020-12-15 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 3 k | 24,18 | 84 k USD |
| 2020-12-15 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 1 k | 5,11 | 5 k USD |
| 2020-12-15 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 380 | 23,63 | 9 k USD |
| 2020-12-15 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 670 | 24,45 | 16 k USD |
| 2020-12-15 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 1 k | 5,11 | 5 k USD |
| 2020-12-15 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 380 | 23,63 | 9 k USD |
| 2020-12-15 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 670 | 24,45 | 16 k USD |
| 2020-12-15 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 7 k | 7,78 | 54 k USD |
| 2020-12-15 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 4 k | 23,66 | 84 k USD |
| 2020-12-15 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 3 k | 24,18 | 84 k USD |
| 2020-12-10 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 10 k | 7,78 | 78 k USD |
| 2020-12-10 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 10 k | 26,04 | 260 k USD |
| 2020-12-10 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 10 k | 7,78 | 78 k USD |
| 2020-12-10 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 10 k | 26,04 | 260 k USD |
| 2020-12-10 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 19 k | 7,78 | 151 k USD |
| 2020-12-10 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 19 k | 25,20 | 489 k USD |
| 2020-12-10 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 19 k | 7,78 | 151 k USD |
| 2020-12-10 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 19 k | 25,20 | 489 k USD |
| 2020-12-09 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 600 | 7,78 | 5 k USD |
| 2020-12-09 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 600 | 25,08 | 15 k USD |
| 2020-12-09 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 600 | 7,78 | 5 k USD |
| 2020-12-09 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 600 | 25,08 | 15 k USD |
| 2020-11-30 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 23,65 | 47 k USD |
| 2020-11-30 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 2 k | 5,11 | 8 k USD |
| 2020-11-30 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 2 k | 24,00 | 36 k USD |
| 2020-11-30 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 2 k | 5,11 | 8 k USD |
| 2020-11-30 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 2 k | 24,00 | 36 k USD |
| 2020-11-30 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 23,65 | 47 k USD |
| 2020-11-17 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 7 k | 7,78 | 54 k USD |
| 2020-11-17 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 7 k | 20,00 | 140 k USD |
| 2020-11-17 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 750 | 5,11 | 4 k USD |
| 2020-11-17 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 750 | 20,00 | 15 k USD |
| 2020-11-17 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 7 k | 7,78 | 54 k USD |
| 2020-11-17 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 7 k | 20,00 | 140 k USD |
| 2020-11-17 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 750 | 5,11 | 4 k USD |
| 2020-11-17 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 750 | 20,00 | 15 k USD |
| 2020-11-13 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 7 k | 7,78 | 54 k USD |
| 2020-11-13 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 7 k | 20,00 | 140 k USD |
| 2020-11-13 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 750 | 5,11 | 4 k USD |
| 2020-11-13 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 750 | 20,00 | 15 k USD |
| 2020-11-13 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 7 k | 7,78 | 54 k USD |
| 2020-11-13 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 7 k | 20,00 | 140 k USD |
| 2020-11-13 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 750 | 5,11 | 4 k USD |
| 2020-11-13 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 750 | 20,00 | 15 k USD |
| 2020-09-15 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 7 k | 7,78 | 54 k USD |
| 2020-09-15 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 7 k | 21,76 | 150 k USD |
| 2020-09-15 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 100 | 22,45 | 2 k USD |
| 2020-09-15 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 750 | 5,11 | 4 k USD |
| 2020-09-15 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 750 | 21,73 | 16 k USD |
| 2020-09-15 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 7 k | 7,78 | 54 k USD |
| 2020-09-15 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 7 k | 21,76 | 150 k USD |
| 2020-09-15 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 100 | 22,45 | 2 k USD |
| 2020-09-15 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 750 | 5,11 | 4 k USD |
| 2020-09-15 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 750 | 21,73 | 16 k USD |
| 2020-08-31 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 11 k | 7,78 | 88 k USD |
| 2020-08-31 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 11 k | 20,01 | 226 k USD |
| 2020-08-31 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 27 k | 7,78 | 208 k USD |
| 2020-08-31 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 27 k | 20,05 | 535 k USD |
| 2020-08-31 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 11 k | 7,78 | 88 k USD |
| 2020-08-31 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 11 k | 20,01 | 226 k USD |
| 2020-08-31 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 27 k | 7,78 | 208 k USD |
| 2020-08-31 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 27 k | 20,05 | 535 k USD |
| 2020-08-31 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 21 k | 5,11 | 108 k USD |
| 2020-08-31 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 21 k | 20,01 | 423 k USD |
| 2020-08-31 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 21 k | 5,11 | 108 k USD |
| 2020-08-31 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 21 k | 20,01 | 423 k USD |
| 2020-08-28 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 4 k | 5,11 | 19 k USD |
| 2020-08-28 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 4 k | 20,04 | 73 k USD |
| 2020-08-28 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 4 k | 5,11 | 19 k USD |
| 2020-08-28 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 4 k | 20,04 | 73 k USD |
| 2020-08-28 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 2 k | 7,78 | 16 k USD |
| 2020-08-28 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 20,01 | 41 k USD |
| 2020-08-28 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 2 k | 7,78 | 16 k USD |
| 2020-08-28 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2 k | 20,01 | 41 k USD |
| 2020-08-28 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 3 k | 7,78 | 20 k USD |
| 2020-08-28 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 3 k | 20,02 | 52 k USD |
| 2020-08-28 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 3 k | 7,78 | 20 k USD |
| 2020-08-28 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 3 k | 20,02 | 52 k USD |
| 2020-08-27 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 7 k | 18,80 | 133 k USD |
| 2020-08-27 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 7 k | 18,80 | 133 k USD |
| 2020-08-26 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 100 | 7,78 | 778 USD |
| 2020-08-26 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 100 | 20,00 | 2 k USD |
| 2020-08-26 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 100 | 7,78 | 778 USD |
| 2020-08-26 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 100 | 20,00 | 2 k USD |
| 2020-08-19 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 635 | 7,78 | 5 k USD |
| 2020-08-19 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 635 | 20,00 | 13 k USD |
| 2020-08-19 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 700 | 5,11 | 4 k USD |
| 2020-08-19 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 700 | 20,00 | 14 k USD |
| 2020-08-19 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 600 | 7,78 | 5 k USD |
| 2020-08-19 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 600 | 20,00 | 12 k USD |
| 2020-08-19 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Buy | 635 | 7,78 | 5 k USD |
| 2020-08-19 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 635 | 20,00 | 13 k USD |
| 2020-08-19 | Lang Matthew | General Counsel & Corp. Secy. | Buy | 600 | 7,78 | 5 k USD |
| 2020-08-19 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 600 | 20,00 | 12 k USD |
| 2020-08-19 | KARBE FRANK | Principal Fin'l & Accounting | Buy | 700 | 5,11 | 4 k USD |
| 2020-08-19 | KARBE FRANK | Principal Fin'l & Accounting | Sell | 700 | 20,00 | 14 k USD |